the company should continue the festivities with lots more news. HEP E,A,Antigen deal all under the belt now with the yanks. All 13yr deals building revs from now on. HepC being tested at the moment. They should have news out on other kits and their vaccination prgram. I can't see to much down side with all this and a market cap of around $10m. Imagine floating this all off in a good biotech market? the value would be much greater than the current market cap IMO. Check it out or go fishing i say-like the chart, some buying and it will travel nicely.
SLT Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
